NIH-supported study highlights increasingly dangerous illicit drug supply, risk of pills not coming from a pharmacy
|
News Releases
Faster approach for starting extended-release naltrexone to treat opioid use disorder shown effective
| En español
NIH-supported clinical trial addresses important barrier to opioid use disorder treatment
|
Federal study shows overdose deaths are felt across generations, emphasizing need to support children and families
|
Analysis of social media language using AI models predicts depression severity for white Americans, but not Black Americans
| En español
Black people with depression used different language than white people to express their thoughts on Facebook
|
Psychoactive cannabis product use higher in states without delta-8 regulations or cannabis legalization
|
NIH-supported research highlights need to better understand psilocybin in context of growing psychedelic use
|
Reduced drug use is a meaningful treatment outcome for people with stimulant use disorders
| En español
NIH-supported findings suggest the need to expand definitions of addiction treatment success beyond abstinence
|
Just seven states had a facility that accepted Medicaid, had a bed open the same day, and offered buprenorphine
|
Semaglutide associated with lower risk of suicidal ideations compared to other treatments prescribed for obesity or type 2 diabetes
| En español
Analysis finds patients treated with semaglutide had 49% to 73% lower risk of suicidal ideation
|
Reported drug use among adolescents continued to hold below pre-pandemic levels in 2023
| En español
New data show relatively low use of illicit substances, and yet overdose death rates among teens have risen
|
Overdose deaths increased in pregnant and postpartum women from early 2018 to late 2021
| En español
Among those aged 35 to 44, overdose mortality more than tripled during this period, NIH study reports
|
Researchers identify brain network that is uniquely activated through injection vs. oral drug use
| En español
NIH study suggests the brain’s “salience network” is important for understanding SUD, possible therapeutic target
|
Federally funded study provides evidence supporting expanded use of telehealth services for opioid use disorder
|
Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder
| En español
NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl
|
Marijuana and hallucinogen use, binge drinking reached historic highs among adults 35 to 50
| En español
For younger adults 19 to 30, marijuana, vaping, hallucinogen use are at or near historically high levels
|
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
| En español
NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care
|
NIH study deepens understanding of possible mechanism through which xylazine impacts overdose risk
|
National data show need for more research into the factors underlying differences in sex-based vulnerability to drug use
|
Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
| En español
NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people
|
NIH and FDA leaders call for more research, lower barriers to improve and implement drug- checking tools amid overdose epidemic
| En español
Tools such as fentanyl test strips hold promise to reduce drug-related harms and save lives
|
NIH study highlights the need to proactively screen for, prevent, and treat cannabis use disorder among young people
|
Anti-poverty programs may help reduce disparities in brain development and mental health symptoms in children
| En español
Study identifies potential of support programs to decrease health impacts of socioeconomic inequities
|
School prevalence of stimulant therapy for ADHD associated with higher rates of prescription stimulant misuse among teens
| En español
NIH study signals importance of monitoring and screening for prescription stimulant misuse in schools
|
Buprenorphine initiation in the ER found safe and effective for individuals with OUD who use fentanyl
| En español
Multi-site NIH study reinforces importance of continued, uninterrupted access to addiction medication
|
Increased Telehealth Services, OUD Medications During COVID-19 Associated with Reduced Fatal Overdose Risk
Study findings support the continuation of providing telehealth services for opioid use disorder and its related care
|
Breakthrough findings could lead to more effective prevention and treatment strategies for multiple SUDs
|
Long-acting antiretroviral therapy suppresses HIV among people with unstable housing, mental illnesses, substance use
| En español
NIH-supported study demonstrates injectable ART may improve outcomes in underserved patients
|
Overdose deaths involving buprenorphine did not proportionally increase with new flexibilities in prescribing
| En español
Federal study findings help understand effects of expanding access to treatment for opioid use disorder
|
Scientists will test community-based approaches to prevent drug overdoses, curb high death rates
|
The 2022 Monitoring the Future Survey reports substance use behaviors & related attitudes among adolescents in the U.S.
|